[1]
P. Bhatia, A. Chauhan, G. Porwal, and V. Shukla, “Regulatory aspects on repurposing of drugs in the management of COVID-19”, Int J Drug Reg Affairs, vol. 10, no. 1, pp. 1-13, Mar. 2022.